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MaBACKGROUND Use of blood oxygenation level-dependent cardiovascular magnetic resonance (BOLD-CMR) to assess
perfusion in the lower limb has been hampered by poor reproducibility and a failure to reliably detect post-
revascularization improvements in patients with critical limb ischemia (CLI).
OBJECTIVES This study sought to develop BOLD-CMR as an objective, reliable clinical tool for measuring calf muscle
perfusion in patients with CLI.
METHODS The calf was imaged at 3-T in young healthy control subjects (n ¼ 12), age-matched control subjects
(n ¼ 10), and patients with CLI (n ¼ 34). Signal intensity time curves were generated for each muscle group and
curve parameters, including signal reduction during ischemia (SRi) and gradient during reactive hyperemia (Grad).
BOLD-CMR was used to assess changes in perfusion following revascularization in 12 CLI patients. Muscle biopsies
(n ¼ 28), obtained at the level of BOLD-CMR measurement and from healthy proximal muscle of patients undergoing
lower limb amputation (n ¼ 3), were analyzed for capillary-ﬁber ratio.
RESULTS There was good interuser and interscan reproducibility for Grad and SRi (all p < 0.0001). The
ischemic limb had lower Grad and SRi compared with the contralateral asymptomatic limb, age-matched control
subjects, and young control subjects (p < 0.001 for all comparisons). Successful revascularization resulted in
improvement in Grad (p < 0.0001) and SRi (p < 0.0005). There was a signiﬁcant correlation between capillary-
ﬁber ratio (p < 0.01) in muscle biopsies from amputated limbs and Grad measured pre-operatively at the
corresponding level.
CONCLUSIONS BOLD-CMR showed promise as a reliable tool for assessing perfusion in the lower limb musculature and
merits further investigation in a clinical trial. (J Am Coll Cardiol 2016;67:420–31) © 2016 by the American College of
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AB BR E V I A T I O N S
AND ACRONYM S
ABPI = ankle-brachial pressure
index
ASL = arterial spin labeling
BOLD = blood oxygenation
level-dependent
C:F = capillary-ﬁber ratio
CLI = critical limb ischemia
CMR = cardiovascular magnetic
resonance
DCE = dynamic contrast
enhanced
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421P eripheral arterial disease (PAD) affects 27million people in North America and Europe(1) and is characterized by progressive devel-
opment of arterial stenoses and occlusions. Most in-
dividuals with PAD are asymptomatic (2), with the
remainder developing intermittent claudication or
critical limb ischemia (CLI). The latter is characterized
by pain at rest, ulceration or gangrene, and high
morbidity and mortality. Up to 25% of patients even-
tually lose a limb (3). Patients with PAD, irrespective
of symptoms, have an increased risk of myocardial
infarction and stroke and are 6 more likely to die
within 10 years (4).SEE PAGE 432
Grad = gradient during
reactive hyperemia
GRE = gradient recalled echo
PAD = peripheral arterial
disease
SRi = signal reduction during
miaThe main treatments for patients with CLI and
intermittent claudication are bypass surgery or an-
gioplasty/stenting, which relieve symptoms and pro-
mote limb salvage. Imaging methods, such as duplex
ultrasonography, cardiovascular magnetic resonance
(CMR), computed tomography (CT), and intra-arterial
angiography inform the extent of disease, aid in plan-
ning interventions, and permit assessment of patency
post-revascularization. These imaging modalities
show the severity of luminal disease in the major pe-
ripheral blood vessels, but do not provide information
on the microcirculation or degree of muscle perfusion
in the affected limb (5), which is the most important
determinant of limb salvage in patients with CLI.
Currently, no reliable method for measuring the
adequacy of lower-limb perfusion exists. A surrogate
for perfusion in the limb, ankle-brachial pressure in-
dex (ABPI) only crudely indicates ﬂow in major leg
vessels and is of limited value in the presence of
calciﬁed arteries. An objective, noninvasive method
of measuring and mapping muscle perfusion would
aid diagnosis and treatment of PAD and may improve
limb salvage rates. This has stimulated studies using
CMR for segmental, serial assessment of perfusion in
the lower limb musculature (6–14).
Blood oxygenation level-dependent (BOLD), arte-
rial spin labeling (ASL), and dynamic contrast en-
hanced (DCE) are different CMR techniques that can
measure segmental perfusion in the lower limb. BOLD
uses the paramagnetic properties of deoxygenated
hemoglobin that induces inhomogeneities in the local
magnetic ﬁeld, resulting in reduced T2* relaxation
times. This was ﬁrst demonstrated when mapping
areas of brain activation, where blood oxygenation is
inversely proportional to T2* relaxation time (15,16).
BOLD-CMR has subsequently been used to delineate
areas of poorly perfused myocardium (17,18), but the
lack of reproducibility and objectivity whenmeasuring
perfusion in the lower limb has limited its utility (12).The present study aimed to: 1) test the
feasibility and reproducibility of using BOLD-
CMR to measure perfusion in the lower limb;
2) use BOLD-CMR to compare perfusion in the
critically ischemic and contralateral (asymp-
tomatic) limb in the same patient, as well as
in limbs of age-matched and young healthy
control subjects; 3) compare changes in
perfusion, measured with BOLD-CMR, before
and after successful revascularization in pa-
tients with CLI; and 4) to provide preliminary
histological validation of BOLD-CMR–derived
parameters.
METHODS
This study complies with the Declaration of
Helsinki and has ethical approval for the
recruitment of patients and volunteers (Guy’s
& St. Thomas’ NHS Foundation Trust10/
H0804/67). All subjects were provided with written
information regarding the study, and written consent
was obtained.
Patients with a clinical diagnosis of CLI (conﬁrmed
by CT angiography or duplex ultrasonography) were
recruited. Age-matched subjects with no clinical
evidence of PAD and young, healthy volunteers
<30 years of age were used as control subjects.
Exclusion criteria included: 1) presence of cardiac
pacemaker/deﬁbrillator or other magnetically active
implants; 2) severe claustrophobia; 3) ﬁxed ﬂexion
deformities of the lower limb where the subject is
unable to place the leg ﬂat on the CMR table; and
4) patients unable to consent.
IMAGING PROTOCOL. To standardize scans, all sub-
jects refrained from caffeine and exercise 4 h before
imaging and rested supine for 5 min. All subjects were
imaged with a 3-T Philips Achieva scanner (Philips
Healthcare, Best, the Netherlands) using a multi-echo
single-shot gradient recalled echo (GRE) sequence.
Reactive hyperemia, instigated by cuff-induced arte-
rial occlusion followed by rapid cuff deﬂation, was
used to elicit T2* changes (Figure 1A, Online Appendix).
A 10-mm slice at the widest part of the calf was
acquired, with a ﬁeld of view including both legs.
Parameters for imaging were as follows: time to repeat
66 ms, 14 echoes with time to echo 4.6 ms, change in
echo time 4.6ms, ﬂip angle 20, ﬁeld of view 288 288,
and voxel size 1.1  1.1  10 mm3. Image acquisition for
the 14 echoes was every 3 s. T2* maps were recon-
structed by a Maximum Likelihood Estimate ﬁt with
Rician noise correction, where noise is read in k-space,
for precise and unbiased automated estimation of T2*.
A T2-weighted turbo spin echo (TSE) image was also
ische
FIGURE 1 Protocol for Evoking Reactive Hyperemia
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(A) Subjects were imaged supine with an occlusive cuff placed around both thighs to
provoke reactive hyperemia. The axial image slice is acquired at the widest part of the
lower leg. (B) In this typical signal intensity time course curve from a healthy volunteer, a
steady T2* signal occurs during the baseline phase (2 min) and declines in intensity during
the ischemic phase (5 min). After cuff deﬂation, a reactive hyperemic response is seen with
an increase in T2* and overshoot before returning to baseline (5 min). Curve parameters
analyzed include gradient (Grad), measured by taking the mean of the highest 10 values of
the ﬁrst derivative during reactive hyperemia, and signal reduction during ischemia (SRi),
measured as a percentage reduction in T2* signal from a mean of the baseline to a
minimum T2* at the end of the ischemic phase. BOLD ¼ blood oxygenation
level-dependent; CMR ¼ cardiovascular magnetic resonance.
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422acquired of the same region of the calf to allow for ac-
curate delineation of muscle compartments.
Regions of interest (ROIs) were drawn around
the 5 muscle groups (anterior, lateral, soleus,gastrocnemius, and deep posterior) in each leg, using
the GRE-BOLD T2* maps with the TSE images
providing a visual guide. All ROIs were adjusted for
any motion artifact and volume changes in the limb.
Bespoke MATLAB (MathWorks, Natick, Massachu-
setts) routines were used to automatically generate
time-course curves for individual ROIs and analyze
curve parameters. In patients with CLI, both the
ischemic limb and the contralateral, asymptomatic
limb were analyzed. The parameters assessed are
shown in Figure 1B and the Online Appendix. T2*
values were normalized to baseline values obtained
prior to cufﬁng to allow comparisons between
subjects.
BOLD-CMR PERFORMANCE AND ANALYSIS. Inde-
pendent analysis of BOLD-CMR images by 2 blinded
users was used to assess interuser variability of
scans from 7 healthy volunteers, 5 of whom had
repeat scans carried out 1 to 5 weeks apart to assess
interscan variability. The tibial tuberosity was used as
an anatomic reference point to ensure imaging at the
same calf level. These images were analyzed by the
same blinded user.
BOLD-CMR was performed before and 1 to 14 days
(median 3 days) after revascularization in 13 patients
with CLI. Intervention involved endovascular and/or
open surgery of the aortic, iliac, common femoral, or
superﬁcial femoral arteries (SFAs). Patients undergo-
ing distal bypasswere excluded because of possible risk
of graft occlusion with cufﬁng and because hematoma
secondary to open surgical intervention below the knee
made interpretation of BOLD-CMR scans difﬁcult.
Successful revascularization of the target vessels was
conﬁrmed by duplex and/or CT angiography and
related toABPImeasured before and after intervention.
BOLD-CMR curve parameters were compared be-
tween patients who had a patent SFA distal to the
recanalized inﬂow vessels and those in whom the SFA
remained occluded to assess their sensitivity to in-
cremental changes in blood ﬂow.
Muscle biopsies from 3 CLI patients undergoing
major lower limb amputation were taken from
healthy muscle proximal to the level of amputation
(n ¼ 13) and from the corresponding level of BOLD-
CMR imaging (n ¼ 15). Used as an anatomic land-
mark, tibial tuberosity helped identify the level of
imaging with BOLD-CMR and biopsies taken from this
level. The capillary-ﬁber (C:F) ratio was assessed by
CD31 and laminin staining. The C:F ratios obtained at
the level of BOLD-CMR imaging were normalized to
the C:F ratio in the healthy proximal muscle in each
patient and correlated with corresponding gradient
during reactive hyperemia (Grad) and signal reduc-
tion during ischemia (SRi) values (Online Appendix).
TABLE 1 Demographics
Young Control
Subjects
(n ¼ 12)
Age-Matched
Control Subjects
(n ¼ 10)
CLI Patients
(n ¼ 37)
Age, yrs 25 (24–28) 67 (52–71) 66 (37–86)
Male to female ratio 8:4 7:3 29:8
Smoker 1 1 26
Hypertension 0 2 29
Hypercholesterolemia 0 1 20
Diabetes 0 0 13
Rutherford classiﬁcation
IV 22
V 9
VI 6
Values are median (range) or n.
CLI ¼ critical limb ischemia.
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423STATISTICAL ANALYSIS. Statistical analysis was
carried out using SPSS version 20 (IBM Corp.,
Armonk, New York) and Prism 5 (GraphPad Software
Inc., La Jolla, California). A 1-way analysis of variance
(with Tukey post-hoc test) was used to analyze curve
parameters. Reproducibility was assessed using
intraclass correlation coefﬁcient (ICC), where an ICC
>0.9 was deemed as excellent level of agreement,
and Bland-Altman analysis. Reproducibility and
analysis of pre- and post-intervention changes in
curve parameters was assessed by paired Student t
test. C:F ratio comparisons between well and poorly
perfused muscle was analyzed using unpaired Stu-
dent t test. Correlation analysis of curve parameters
against C:F ratio and ABPI was performed using
Spearman’s correlation. Curve parameters were
compared in patients with a patent or occluded SFA
using a Mann Whitney U test. All values are given as
mean  SD, and p < 0.05 was deemed statistically
signiﬁcant.
RESULTS
A total of 37 patients with CLI, 10 age-matched control
subjects, and 12 young healthy control subjects were
recruited into the study (Table 1, Online Figure 1).
Three CLI patients were excluded, as they were un-
able to lie supine long enough to undergo CMR
because of rest pain severity.
A T2-weighted TSE image allowed accurate visual
delineation of muscle groups (Figure 2A). A high
spatial resolution was achieved with the GRE-BOLD-
CMR sequence, which allowed for accurate exclu-
sion of major blood vessels, bone, and soft tissue from
muscle ROIs (Figure 2B). T2* perfusion maps highlight
changes in muscle perfusion during cufﬁng and
reactive hyperemia (Figures 2C and 2D).
Automated analysis identiﬁed Grad and SRi as the
most informative in discriminating between ischemic
and patient contralateral limbs (p < 0.0001 for both)
(Table 2, Online Appendix).
BOLD-CMR REPRODUCIBILITY. There was good
interuser (A.B., R.W.) reproducibility as evidenced by
strong correlations for both Grad and SRi measure-
ments (ICC: 0.99; 95% conﬁdence interval [CI]: 0.98 to
0.99; and ICC: 0.99; 95% CI: 0.98 to 0.99, respectively;
p < 0.0001 for both) (Figures 3A and 3B). Bland-Altman
analysis concurred with ICC (Grad: mean bias 0.002;
95% limits of agreement: 0.05 to 0.05; SRi: mean
bias 0.04; 95% limits of agreement: 1.79 to 1.70)
(Figures 3C and 3D). Similar T2* curves were generated
by the 2 users. No signiﬁcant difference was found
between Grad and SRi measured by each of the 2 in-
vestigators (Online Figure 2A).There also were excellent interscan (A.B.) correla-
tions for Grad and SRi in the same subject (ICC: 0.95;
95% CI: 0.90 to 0.98; and ICC: 0.96; 95% CI: 0.90 to
0.98, respectively; p < 0.0001 for both) (Figures 3E and
3F). Bland-Altman analysis conﬁrmed good reproduc-
ibility between scans for Grad (mean bias: 0.0004; 95%
limits of agreement: 0.14 to 0.14) and SRi (mean
bias: 0.92; 95% limits of agreement: 4.88 to 3.04)
(Figures 3G and 3H). No signiﬁcant difference was
found for Grad and SRi between interval scans for all
muscle groups analyzed (Online Figure 2B).
Comparison of the T2* signal intensity curves for
each of the 5 muscle groups demonstrated a clear
difference between ischemic limbs and control limbs,
with the soleus muscle generating the most distinc-
tive curve characteristics (Figure 4A). In all groups,
T2* signal fell after cuff inﬂation during the ischemic
phase, but the signal for the ischemic limbs plateaued
sooner than the other groups and the total reduction
in signal intensity was much less. During reactive
hyperemia, the rise in T2* signal was faster in the
young control subjects and most delayed in the
ischemic limbs of CLI patients. A signiﬁcantly lower
Grad was measured in the ischemic limb (0.17 
0.11 ms/s) compared with the patient contralateral
(0.28  0.14 ms/s; p < 0.001), age-matched control
subjects (0.38  0.17 ms/s; p < 0.001), and young
control limbs (0.47  0.16 ms/s; p < 0.001) (Figure 4B).
Similarly, the SRi was lower in the ischemic limb (8.68
 5.11%) compared with the patient contralateral
(11.03  5.62%; p < 0.001), age-matched control sub-
jects (13.77  6.33%; p < 0.001), and young control
subjects (14.07  5.09%; p < 0.001) (Figure 4C).
The ABPI, measured in the ischemic limb of CLI
patients, was correlated with corresponding Grad and
SRi values. ABPI was only measurable in 19 of the 34
FIGURE 2 BOLD T2* Mapping CMR and Perfusion Maps
(A) T2-weighted anatomic images allow for more accurate delineation of muscle compartments when selecting regions of interest. (B) Gradient
recalled echo (GRE) sequence for accurate mapping of T2* signal affords high spatial resolution allowing for accurate delineation on the T2*
maps of different muscle groups in the lower leg (green outlines: A ¼ anterior; L ¼ lateral; S ¼ soleus; G ¼ gastrocnemius; D ¼ deep) and
exclusion of major blood vessels (red outline), bone (star), and other soft tissue. T2* perfusion maps demonstrate changes in perfusion as
measured by T2* signal intensity in the calf of a chronic limb ischemia (CLI) patient during cufﬁng (C) and reactive hyperemia (D). Increased
signal intensity is seen in all muscle groups after release of the cuff. Abbreviations as in Figure 1.
TABLE 2 Analysis of Curve Parameters
Patient
Contralateral
Limbs Ischemic Limbs p Value
Grad, ms/s 0.28  0.14 0.17  0.11 0.0001
SRi, % 11.03  5.62 8.68  5.11 0.0001
Minimum T2*, ms 21.99  3.63 22.80  3.62 0.01
Baseline (start), ms 24.70  4.09 25.04  3.92 0.16
Baseline (end), ms 24.64  4.07 24.85  3.93 0.43
Maximum T2*, ms 24.93  4.25 24.56  3.93 0.20
TTP, s 68.7  22.76 64.5  29.7 0.14
THIM, s 205.5  78.3 195.5  81.5 0.24
Values are mean  SD.
Grad ¼ gradient during reactive hyperemia; SRi ¼ signal reduction during
ischemia; THIM ¼ time to half ischemia; TTP ¼ time to peak.
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Either calciﬁcation in the below-knee arteries or
absence of a Doppler signal precluded reliable mea-
surement in the remaining 15 patients. The measured
ABPI values did not correlate with either Grad or SRi
(Grad: r ¼ 0.34 and SRi: r ¼ 0.07; p > 0.05 for both)
(Online Figures 3A and 3B).
Differences in T2* response and curve parameters
was analyzed in CLI patients for age, smoking history,
and diabetes. CLI patients age <65 years had signiﬁ-
cantly higher Grad and SRi compared with patients
age $65 years (p < 0.005 for both). No signiﬁcant
difference in Grad and SRi was seen between smokers
and nonsmokers or patients with or without diabetes
(Online Figure 4).
BOLD-CMR MEASUREMENT OF LIMB PERFUSION
AFTER REVASCULARIZATION. BOLD-CMR was
carried out prior to and after revascularization in
FIGURE 3 Reproducibility of BOLD-CMR Scans
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(A to D) Interuser reproducibility was tested using intraclass correlation coefﬁcient (ICC) by 2 different users analyzing identical scans from 7 healthy volunteers and
Bland-Altman analysis. (E to H) Interscan reproducibility was determined by analysis of interval scans that were carried out 1 to 5 weeks apart by a single user in 5
subjects. Bland-Altman analysis conﬁrmed good reproducibility for Grad (C for A, G for E) and SRi (D for C, H for F). CI ¼ conﬁdence interval; other abbreviations as
in Figure 1.
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42513 patients (Online Table 1). One patient was excluded
because of the presence of signiﬁcant edema on both
pre- and post-intervention imaging. T2* curves in the
ischemic limb generated prior to revascularization
were consistent with curves typical of limbs with
impaired perfusion (Figure 5A). This was conﬁrmed
by signiﬁcantly lower Grad and SRi measurements
compared with both the contralateral asymptomatic
legs (Grad: 0.14  0.10 ms/s vs. 0.28  0.14 ms/s;
p < 0.0001; and SRi: 8.08  5.04% vs. 11.03  5.62%;
p < 0.005) and age-matched control subjects
(Grad: 0.38  0.17 ms/s; p < 0.0001; and SRi: 13.77 
6.33%; p < 0.0001).
Revascularization resolved rest pain in all
patients and successfully healed tissue loss in all but 1
patient, who required bypass surgery because of stent
occlusion 3 months post-intervention. Improved
ABPIs were measured in 8 patients. In 5 patients, ABPI
was not measurable either pre- or post-operatively
due to crural vessel calciﬁcation (Figure 5B).Repeat BOLD-CMR after revascularization resulted
in T2* curves consistent with improved perfusion,
resembling those generated from the patient contra-
lateral limbs (Figure 5A). There were signiﬁcant
improvements in Grad and SRi after limb revascular-
ization (Grad: 0.14  0.10 ms/s vs. 0.32  0.18 ms/s;
p < 0.0001; and SRi 8.08  5.04% vs. 11.57  6.31%;
p < 0.005) (Figures 5C and 5D), suggesting that inter-
vention had increased perfusion in the calf.
Patients in whom the SFA was patent (n ¼ 9)
demonstrated a larger-fold increase in Grad compared
with those in whom the SFA remained occluded
(n ¼ 3) after proximal revascularization (3.49  2.56
vs. 1.87  0.73; p < 0.05) (Figure 5E). A similar trend
was observed for SRi (3.12  6.16 with patent SFA vs.
1.81  1.27 with occluded SFA; p > 0.05) (Figure 5F).
Patency of the SFA had no signiﬁcant effect on the
fold change in ABPI after intervention (2.56  1.61
with patent SFA vs. 2.86  0.49 with occluded SFA;
p > 0.05) (Figure 5G). The change in ABPI that
FIGURE 4 BOLD-CMR T2* Signal Changes
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(A) Mean signal intensity time course curves for the 5 muscle groups (anterior, lateral, soleus, gastrocnemius, and deep) highlight differences in T2* signal
intensity provoked by reactive hyperemia. Consistent differences, particularly during ischemia and reactive hyperemia, are seen among the young control
subjects (blue), age-matched control subjects (orange), the patient’s contralateral limb (gray), and the patient’s ischemic limb (red). Values (mean  SD)
for Grad (B) and SRi (C) are signiﬁcantly lower in the ischemic limb compared with the patients’ contralateral limb, age-matched control subjects, and young
healthy control subjects. ANOVA ¼ analysis of variance; other abbreviations as in Figure 1.
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FIGURE 5 T2* Signal Changes After Limb Revascularization
1.1
1.0
0.9
0.8
0 120 240 360 480 600 720
Time (Sec)
No
rm
al
iz
ed
 T
2*
1.1
1.0
0.9
0.8
0 120 240 360 480 600 720
Time (Sec)
No
rm
al
iz
ed
 T
2*
1.1
1.0
0.9
0.8
0 120 240 360 480 600 720
Time (Sec)
No
rm
al
iz
ed
 T
2*
1.1
1.0
0.9
0.8
0 120 240 360 480 600 720
Time (Sec)
No
rm
al
iz
ed
 T
2*
1.1
1.0
0.9
0.8
0 120 240 360 480 600 720
Time (Sec)
No
rm
al
iz
ed
 T
2*
Anterior Lateral Soleus Gastrocnemius Deep
6
4
2
0
SFA Patent
(n=9)
SFA Occluded
(n=3)
Gr
ad
 F
ol
d 
Ch
an
ge
6
4
2
0
SFA Patent
(n=9)
SFA Occluded
(n=3)
SR
i F
ol
d 
Ch
an
ge
6
4
2
0
SFA Patent
(n=5)
SFA Occluded
(n=3)
AB
PI
 F
ol
d 
Ch
an
ge
p<0.05 p=ns p=ns
p<0.01 p<0.0001 p<0.0001 p<0.0005 p<0.0005
(i) (ii) (i) (ii)
1.5
1.0
0.5
0.0
Pre
(n=5)
Post
(n=8)
Pre
(n=12)
Post
(n=12)
Pre
(n=12)
Post
(n=12)
Pre
(n=12)
Post
(n=12)
Pre
(n=12)
Post
(n=12)
1.0
0.8
0.6
0.4
0.2
0.0
0.6
0.4
0.2
0.0
40
30
20
10
0
20
15
10
5
0
AB
PI
Gr
ad
ie
nt
 (m
s/
s)
Gr
ad
 (m
s/
s)
SR
i (
%
)
SR
i (
%
)
A
B C D
E F G
Pre Intervention (n=12)
Post Intervention (n=12)
Patient Control
(A) Mean T2* signal intensity time course curves, shown for the 5 muscle groups in CLI patients’ ischemic limb (n ¼ 12) pre- (blue) and post-revascularization
(orange), improve signiﬁcantly after intervention, with curves from revascularized limbs changing to resemble control limbs (gray). Revascularization also signiﬁcantly
improved ankle-brachial pressure index (ABPI) (B), Grad (C), SRi (D) (ii ¼ mean  SD), and Grad-fold change in patients with a patent versus occluded superﬁcial
femoral artery (SFA) (E). No signiﬁcant changes were seen in SRi-fold (F) or ABPI-fold (G) change when comparing patent and occluded SFAs. Abbreviations as in
Figures 1 and 2.
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428occurred after limb revascularization did not corre-
late with changes in either Grad or SRi. (r ¼ 0.05 and
r ¼ 0.07, respectively; p > 0.05 for both) (Online
Figures 5A and 5B).
Analysis of biopsies from well-perfused muscle
proximal to the amputation level shows a signiﬁ-
cantly higher C:F ratio compared with biopsies from
the level of BOLD-CMR imaging (2.97  0.79 vs. 4.15 
0.92; p < 0.001) (Online Appendix, Online Figure 6).
The Grad and SRi values measured at calf level in the
amputated limbs were correlated with C:F ratios at
the corresponding level. There was a signiﬁcant cor-
relation between Grad and C:F ratio (r ¼ 0.64;
p < 0.01), but none was observed with SRi (r ¼ 0.25;
p > 0.05) (Figure 6).
DISCUSSION
We believe that the present study is the ﬁrst to
consistently demonstrate that BOLD-CMR is an
objective and reproducible tool for measuring muscle
perfusion in the lower limb. Distinct T2* curve pa-
rameters were consistently obtained from critically
ischemic limbs and control subjects, allowing typical
values to be assigned to each group. In the largest
cohort of patients studied to date, BOLD-CMR showed
an improvement in perfusion after successful limb
revascularization (Central Illustration).
BOLD-CMR is superior to ASL, an alternative non-
contrast CMR-based technique, for measuring perfu-
sion because it has a better signal-to-noise ratio and
requires a shorter scan time, reducing motion artifact
(5). Unlike DCE-CMR, BOLD does not require theFIGURE 6 Histological Validation of BOLD-CMR–Derived Parameters
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ments but not with SRi (B). Abbreviations as in Figure 1.administration of gadolinium-based contrast agents,
avoiding the possibility of nephrogenic systemic
ﬁbrosis in patients with renal impairment. One
advantage of ASL and DCE sequences is that, unlike
BOLD, they allow absolute quantiﬁcation of perfu-
sion, but this is dependent on tracer kinetic
modeling, which can introduce inaccuracies (19).
To determine whether BOLD-CMR–derived pa-
rameters (Grad and SRi) reﬂect the extent of tissue
vascularity, these were correlated with the C:F ratio
determined using histological analysis of corre-
sponding muscle biopsies from amputated limbs.
Only Grad showed a positive correlation with C:F ra-
tio, suggesting that this parameter may be sensitive
to the extent of tissue vascularity in the ischemic calf.
The GRE-BOLD-CMR sequence-based strategy used
in the present study is superior to standard BOLD
sequences because: 1) it achieves a higher spatial
resolution, allowing for accurate exclusion of major
blood vessels, bone, and other soft tissue, which
avoids erroneous T2* quantiﬁcation caused by inad-
vertently including these structures; 2) the larger
number of echoes and imaging at 3-T enables more
accurate quantiﬁcation of T2* (20); and 3) it uses
semiautomated analysis of signal intensity curves
that improves reproducibility and objectivity by cir-
cumventing the need for manual selection of refer-
ence points on the generated T2* curve.
Consistent with previous reports using BOLD-CMR,
our study demonstrates a greater fall in T2* signal
during cufﬁng of the control versus ischemic limbs
(11). The earlier leveling off in T2* signal after cufﬁng
in CLI patients may represent a reduced physiological1.5
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CENTRAL ILLUSTRATION Critical Limb Ischemia and Changes With Revascularization
Bajwa, A. et al. J Am Coll Cardiol. 2016; 67(4):420–31.
(A) Computed tomographic angiogram demonstrates right common and external iliac artery occlusion (red dashed line) in a patient with critical limb ischemia. T2* signal
heat map during reactive hyperemia shows low perfusion in all muscle groups in the right calf. (B) Blood oxygenation level-dependent cardiovascular magnetic
resonance (BOLD-CMR), performed after right femoral endarterectomy and iliac angioplasty/stenting, detects improved perfusion in all calf muscle groups. (C) Typical
T2* signal intensity curves are shown prior to and after limb revascularization.
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429reserve of muscle to ischemic stress in these patients
(21). Similarly, the slower rise in T2* signal seen
during reactive hyperemia in CLI patients may be due
to less efﬁcient delivery of oxygenated hemoglobin to
muscle.
In patients with CLI, we measured a higher Grad
and SRi in the soleus compared with the lateral and
deep muscle groups. This may be a reﬂection of the
soleus’ larger muscle mass, allowing a more accurate
quantiﬁcation of T2* signal intensity with generation
of smoother curves. The soleus muscle is also different
in that it has a dual supply from both the posterior
tibial and peroneal vessels and is predominantly
red muscle composed of Type 1 oxidative ﬁbers,
which may also inﬂuence the BOLD signal (22,23).ABPI is currently used for conﬁrming PAD diag-
nosis and for assessing improvements in blood ﬂow to
the foot after revascularization. Unlike BOLD-CMR,
ABPI cannot, however, be measured in all patients.
The present study’s results reﬂect this, as we were
unable to measure ABPI in w40% of the patients with
CLI. There was no correlation between ABPI values
and corresponding Grad or SRi, the former measuring
global blood ﬂow into the limb rather than perfusion
at tissue level. It should be noted, however, that the
combination of clinical examination and ABPI re-
mains a practical, simple, and useful tool to initially
assess of the critically ischemic limb.
Our study suggests that BOLD-CMR may help
to assess changes in perfusion in the immediate
PERSPECTIVES
COMPETENCY IN PATIENT CARE AND
PROCEDURAL SKILLS: Methods to accurately
measure tissue perfusion in the ischemic limb are
relatively cumbersome and currently not widely
adopted in clinical practice, but CMR imaging tech-
niques are being developed to address this. BOLD and
ASL CMR can measure perfusion in the calf muscula-
ture and detect changes in perfusion after limb
revascularization.
TRANSLATIONAL OUTLOOK: Clinical studies are
needed in which CMR perfusion measurements are
combined with CMR angiographic imaging to guide
management and outcomes are compared to those
resulting from conventional assessment strategies.
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430post-intervention period. It can also detect incre-
mental changes in perfusion related to the status of
the inﬂow vessels (i.e., patency of the SFA post-
revascularization in the present study), which ABPI
does not discriminate. All of the patients in the
intervention group resolved symptoms, and there-
fore, future studies should include patients with a
high risk of intervention failure to see if, at an early
stage, BOLD-CMR can reliably identify those who
require further intervention. BOLD-CMR sequences
could also readily be added to MR angiography
studies to provide both functional and anatomic in-
formation simultaneously.
STUDY LIMITATIONS. One limitation of BOLD-CMR
is its utility in patients undergoing distal bypass,
where edema and hematoma in the ﬁeld of view
may preclude accurate assessment of T2* signal.
Occlusion of the bypass with prolonged cufﬁng also
may threaten the graft. Not all CLI patients were able
to remain still for the duration of the BOLD-CMR due
to the presence of rest pain when supine. Although
dynamic imaging took only 12 min, this remains still
sufﬁciently long for some patients not to tolerate
the scan.
CONCLUSIONS
The present study shows that BOLD-CMR consistently
detects perfusion deﬁcits in the ischemic limb
and quantiﬁes improvements in perfusion after
revascularization. A reliable method for assessing
segmental muscle perfusion in the limb would faci-
litate rapid detection of changes in perfusion to
determine adequacy of revascularization procedures.BOLD-based perfusion metrics may also provide
assessment of pharmacological and cell-based angio-
genic therapies being tested as part of clinical studies
and merits further investigation in a clinical trial.
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